Based on the study type of cancer SMR, there was no statistical significance between growth hormone therapy and tumor mortality in retrospective cohorts (SMR = 1.47, 95% CI: 0.73–2.96, P = 0.279; I2 = 59.3%; Tau2 = 0.227). Here, GH1 is linked to cancer.